As of 2025-10-25, the Intrinsic Value of Pharmadrug Inc (PHRX.CN) is -1.17 CAD. This PHRX.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.01 CAD, the upside of Pharmadrug Inc is -11,785.00%.
Based on its market price of 0.01 CAD and our intrinsic valuation, Pharmadrug Inc (PHRX.CN) is overvalued by 11,785.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.17 - -1.17 | -1.17 | -11,785.00% |
| DDM - Stable | (0.11) - 0.27 | 0.08 | 690.6% |
| DDM - Multi | (4.43) - 8.26 | (18.55) | -185572.5% |
| Market Cap (mil) | 1.05 |
| Beta | -0.40 |
| Outstanding shares (mil) | 104.56 |
| Enterprise Value (mil) | 1.05 |
| Market risk premium | 5.10% |
| Cost of Equity | 4.49% |
| Cost of Debt | 5.00% |
| WACC | 4.60% |